Related Experiment Video
Updated: Jul 16, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Dual Activation of GLP-1 and AMPK Pathways by a Multi-Botanical Formulation Improves Obesity and Metabolic
Anna Goc1, Waldemar Sumera1, Aleksandra Niedzwiecki1
1Dr. Rath Research Institute BV, 5941 Optical Ct., San Jose, CA 95138, USA.
Background:
Obesity is a multifactorial metabolic disorder characterized by excessive adiposity, chronic low-grade inflammation, and dysregulated incretin and energy-sensing pathways, including glucagon-like peptide-1 (GLP-1) and AMP-activated protein kinase (AMPK).
Methods:
This in vitro and in vivo study evaluated the potential of select phytochemical candidates and botanical formulations to stimulate GLP-1 secretion and activate AMPK signaling.
Results:
Fourteen phytochemicals and six combinations were screened in human NCI-H716 enteroendocrine cells at 10-20 µg/mL to assess cytotoxicity and GLP-1 secretion. In human adipocytes, selected combinations reduced lipid accumulation and monocyte chemoattractant protein-1 (MCP-1) secretion. Among the tested formulations, combination #4, consisting of ginseng root extract, curcumin, white kidney bean extract, fenugreek extract, capsaicin, and bitter melon extract, significantly increased phosphorylated AMPK levels in vitro. In high-fat diet-induced obese mice, oral administration of combination 4 reduced body weight gain and white adipose tissue mass, improved metabolic biochemical parameters, restored leptin and MCP-1 levels toward normal values, increased GLP-1 level, and normalized GLP-1 receptor expression in subcutaneous adipose tissue.
Conclusions:
These preclinical findings demonstrate that this multi-component botanical formulation modulates GLP-1 secretion, AMPK phosphorylation, lipid accumulation, and inflammatory markers in cellular and murine models. These data provide a foundational rationale for its further evaluation as a non-toxic candidate for metabolic management.
Insights
A botanical formulation containing ginseng, curcumin, and other extracts was found to boost GLP-1 secretion and activate AMPK signaling. This natural compound reduced obesity markers in cell and animal models, showing potential for metabolic health management.
Area of Science:
- Metabolic Health and Endocrinology
- Nutraceutical Research
- Obesity Pathophysiology
Background:
- Obesity is a complex metabolic disorder linked to inflammation and disrupted energy regulation pathways.
- Key pathways involved include glucagon-like peptide-1 (GLP-1) secretion and AMP-activated protein kinase (AMPK) signaling.
Purpose of the Study:
- To investigate phytochemicals and botanical formulations for their ability to stimulate GLP-1 secretion.
- To evaluate the potential of these compounds to activate AMPK signaling pathways.
Main Methods:
- Screening of 14 phytochemicals and 6 combinations in human enteroendocrine cells for GLP-1 secretion and cytotoxicity.
- Testing selected combinations in human adipocytes to assess effects on lipid accumulation and MCP-1 secretion.
- In vivo studies using high-fat diet-induced obese mice to evaluate the efficacy of a promising botanical combination (Combination 4).
Main Results:
- Combination 4, featuring ginseng, curcumin, white kidney bean, fenugreek, capsaicin, and bitter melon, significantly increased AMPK phosphorylation in vitro.
- In obese mice, Combination 4 reduced body weight gain, white adipose tissue mass, and improved metabolic parameters.
- The formulation increased GLP-1 levels and normalized GLP-1 receptor expression in adipose tissue, while restoring leptin and MCP-1 levels.
Conclusions:
- The multi-component botanical formulation effectively modulates GLP-1 secretion, AMPK phosphorylation, lipid accumulation, and inflammation markers.
- Preclinical data support this formulation as a non-toxic candidate for further investigation in metabolic management.
- These findings provide a scientific basis for exploring botanical interventions in obesity and related metabolic disorders.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Dipeptidyl Peptidase 4 Inhibitors
cAMP-dependent Protein Kinase Pathways
Global Regulatory Systems
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution